![Integrase inhibitors / Abacavir / Cyclopropanes / Purines / Antiretroviral drug / HIV/AIDS / Lamivudine / Reverse-transcriptase inhibitor / ViiV Healthcare / Biology / Chemistry / Organofluorides Integrase inhibitors / Abacavir / Cyclopropanes / Purines / Antiretroviral drug / HIV/AIDS / Lamivudine / Reverse-transcriptase inhibitor / ViiV Healthcare / Biology / Chemistry / Organofluorides](https://www.pdfsearch.io/img/c5e756c483bd9b39f54c6028d7480e61.jpg)
| Document Date: 2015-01-27 14:49:56 Open Document File Size: 168,86 KBShare Result on Facebook
City Osaka / London / / Company ViiV Healthcare Ltd. / Shionogi & Co. Ltd. / Corporate Communications Shionogi & Co. Ltd. / / Country Japan / United States / / Event FDA Phase / / / IndustryTerm treatment of HIV / foreign healthcare reforms / with respect to product / / MedicalCondition HIV infection / HIV / / Organization European Union / United States Food and Drug Administration / European Commission / / Person Isao Teshirogi / Dominique Limet / / / Position President & CEO / Chief Executive Officer / / Product abacavir / lamivudine / Tivicay® / /
SocialTag |